EcoDrugPlus

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSPEMG00000013461
Gene Symbol: GRM2
3 Cross references
276 Possible Orthologues:

Glutamate Receptor, Ionotropic, Nmda2d (Epsilon 4)

Ensembl ID : ENSPEMG00000015228
Gene Symbol: GRIN2D
1 Cross references
278 Possible Orthologues:

Glutamate Receptor, Ionotropic, Nmda3b

Ensembl ID : ENSPEMG00000024157
Gene Symbol: GRIN3B
1 Cross references
286 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 3

Ensembl ID : ENSPEMG00000020816
Gene Symbol: GRIK3
1 Cross references
256 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 4

Ensembl ID : ENSPEMG00000019743
Gene Symbol: GRIK4
1 Cross references
261 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSPEMG00000019638
Gene Symbol: GRM3
1 Cross references
215 Possible Orthologues:

Glutamate Receptor, Metabotropic 4

Ensembl ID : ENSPEMG00000008393
Gene Symbol: GRM4
1 Cross references
273 Possible Orthologues:

Glutamate Receptor, Metabotropic 5

Ensembl ID : ENSPEMG00000022095
Gene Symbol: GRM5
1 Cross references
272 Possible Orthologues:

Glutaminase

Ensembl ID : ENSPEMG00000017208
Gene Symbol: GLS
1 Cross references
305 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSPEMG00000009695
Gene Symbol: GSK3A
1 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSPEMG00000013248
Gene Symbol: GSK3B
3 Cross references
241 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSPEMG00000019584
Gene Symbol: GHRHR
1 Cross references
191 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).